Tourmaline Bio
TRML
TRML
101 hedge funds and large institutions have $464M invested in Tourmaline Bio in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
14% less capital invested
Capital invested by funds: $541M → $464M (-$77.1M)
65% less call options, than puts
Call options by funds: $89K | Put options by funds: $251K
Holders
101
Holding in Top 10
5
Calls
$89K
Puts
$251K
Top Buyers
| 1 | +$12.2M | |
| 2 | +$7.87M | |
| 3 | +$4.24M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
+$3.5M |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$8.7M | |
| 3 | -$6.21M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$3.33M |
| 5 |
Millennium Management
New York
|
-$2.94M |